Top Research Archives - Page 2 of 3 - PsychPartners

Melatonin-Ashwagandha Combination for Sleep

Hypnotics Research Research for the Public Sleep Supplements Top Research

Melatonin-Ashwagandha Combination for Sleep

April 29, 2026by Chris Aiken, MD0

Naltrexone-Baclofen Combo for Alcohol Craving

Addiction Meds Alcohol Medications Research Substance Use Top Research

Naltrexone-Baclofen Combo for Alcohol Craving

April 28, 2026by Chris Aiken, MD1

Ketamine and Liver Risk: How Worried Should You Be?

Depression Difficult to Treat Depression Ketamine Medications Side Effects Top Research

Ketamine and Liver Risk: How Worried Should You Be?

April 22, 2026by Chris Aiken, MD0

tDCS for Treatment-Resistant Depression

Depression Difficult to Treat Depression Research Research for the Public Top Research

tDCS for Treatment-Resistant Depression

April 6, 2026by Chris Aiken, MD0

Mirtazapine Reduces Meth Use

Addiction Meds Methamphetamine Research Top Research

Mirtazapine Reduces Meth Use

April 2, 2026by Chris Aiken, MD2

Milsaperidone (Bysanti) Approved in Bipolar and Schizophrenia

Antipsychotics Bipolar Meds Research Schizophrenia and Psychosis Top Research

Milsaperidone (Bysanti) Approved in Bipolar and Schizophrenia

March 30, 2026by Chris Aiken, MD3

Quetiapine vs Lithium for Treatment-Resistant Depression

Antipsychotics Depression Difficult to Treat Depression Lithium Research Top Research

Quetiapine vs Lithium for Treatment-Resistant Depression

March 23, 2026by Chris Aiken, MD0

Dextromethorphan Helps When Clozapine Fails in Schizophrenia

Antipsychotics Clozapine Research Schizophrenia and Psychosis Top Research

Dextromethorphan Helps When Clozapine Fails in Schizophrenia

March 18, 2026by Chris Aiken, MD5

Flow: At-home tDCS Approved for Depression

Depression Neuromodulation/TMS Research Research for the Public Top Research

Flow: At-home tDCS Approved for Depression

March 17, 2026by Chris Aiken, MD0

A Wearable Headset for Difficult-to-Treat Depression

Depression Devices Difficult to Treat Depression Neuromodulation/TMS Research Research for the Public Top Research

A Wearable Headset for Difficult-to-Treat Depression

March 15, 2026by Chris Aiken, MD0

When to Stop: An Expert Consensus on Deprescribing Psychotropics

Deprescribing Geriatric Psychiatry Medications Research Top Research

When to Stop: An Expert Consensus on Deprescribing Psychotropics

March 11, 2026by Chris Aiken, MD0

Do ADHD Meds Cause Tolerance?

ADHD Medications Research Research for the Public Stimulants Top Research

Do ADHD Meds Cause Tolerance?

February 2, 2026by Chris Aiken, MD0

Two GLP-1 Agonists Fail in Dementia

Dementia GLP1 Agonists Research Top Research

Two GLP-1 Agonists Fail in Dementia

January 25, 2026by Chris Aiken, MD0

Semaglutide (Ozempic) in Depression

Cognition Depression GLP1 Agonists Research Research for the Public Top Research

Semaglutide (Ozempic) in Depression

December 5, 2025by Chris Aiken, MD0

Lavender for Depression

Depression Research Supplements Top Research

Lavender for Depression

September 27, 2025by Chris Aiken, MD0

Brexpiprazole (Rexulti) in PTSD

Antipsychotics Medications PTSD Research Top Research

Brexpiprazole (Rexulti) in PTSD

September 21, 2025by Chris Aiken, MD0

Saffron for Depression in a Large Trial

Depression Research Supplements Top Research

Saffron for Depression in a Large Trial

July 22, 2025by Chris Aiken, MD0

A New Version of the STAR*D Trial

Antidepressants Depression Difficult to Treat Depression Lithium Medications Top Research

A New Version of the STAR*D Trial

June 18, 2025by Chris Aiken, MD0

Pramipexole for Treatment-Resistant Depression

Depression Research Top Research

Pramipexole for Treatment-Resistant Depression

June 15, 2025by Chris Aiken, MD0

Guanfacine for Aggression in Prader-Willi Syndrome

Child Psychiatry Medications Research Top Research

Guanfacine for Aggression in Prader-Willi Syndrome

May 21, 2025by Chris Aiken, MD0